CDC Says As Of Aug 23, 9 BA.2.86 Variant Sequences Have Been Reported Globally: Denmark (3); South Africa (2); Israel (1); United States (2) And U.K.(1)
Portfolio Pulse from Benzinga Newsdesk
The CDC has reported 9 instances of the BA.2.86 variant globally as of August 23, with cases in Denmark, South Africa, Israel, the United States, and the U.K. The news may impact pharmaceutical companies involved in COVID-19 vaccine production.
August 23, 2023 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
AstraZeneca may be impacted by the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for AstraZeneca.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
BioNTech may see an impact due to the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for BioNTech.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
Johnson & Johnson may be impacted by the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for Johnson & Johnson.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
Moderna may be impacted by the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for Moderna.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
Novavax may be impacted by the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for Novavax.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50
NEUTRAL IMPACT
Pfizer may be impacted by the emergence of the BA.2.86 variant, potentially affecting demand for its COVID-19 vaccine.
The emergence of a new variant could potentially increase demand for vaccines, but it could also mean that existing vaccines are less effective. This creates uncertainty for Pfizer.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 50